Pamela Misajon

Pamela Misajon

Direktor/Vorstandsmitglied bei KIROMIC BIOPHARMA, INC.

Vermögen: 70 125 $ am 30.04.2024

65 Jahre
Health Technology
Consumer Services
Electronic Technology

Ursprung des Netzwerks ersten Grades von Pamela Misajon

EinheitArt der EinheitIndustrie
9
Holding Company Electronic Equipment/Instruments 9
Public Company Biotechnology 8
5
Subsidiary Biotechnology 5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Pamela Misajon

UnternehmenSektorVerknüpfte PersonenHauptposition
JOHNSON & JOHNSON Pharmaceuticals: Major

David M. Clapper

David Renzi

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Dennis Condon

Patricia Altavilla

Corporate Officer/Principal

Sales & Marketing

SVB FINANCIAL GROUP Regional Banks

David M. Clapper

Director/Board Member

Investment Managers

Brian E. Chee

Consultant / Advisor

Telecommunications Equipment

David M. Clapper

Director/Board Member

Medical Specialties

David M. Clapper

Director/Board Member

PULMONX CORPORATION Medical Specialties

David M. Clapper

David Renzi

Director/Board Member

Sales & Marketing

MINERVA SURGICAL, INC. Medical Specialties

David M. Clapper

David Renzi

Chief Executive Officer

Director/Board Member

Pharmaceuticals: Major

Michael C. Brower

Director of Finance/CFO

Recreational Products

Michael C. Brower

Director of Finance/CFO

Packaged Software

Brian E. Chee

Director/Board Member

Investment Banks/Brokers

Brian E. Chee

Corporate Officer/Principal

Medical Specialties

David M. Clapper

David Renzi

Director/Board Member

Sales & Marketing

Bowling Green State University College/University

David M. Clapper

Undergraduate Degree

California State University-Chico College/University

Michael C. Brower

Undergraduate Degree

SPY INC Specialty Stores

Michael C. Brower

Director of Finance/CFO

University of San Diego College/University

Michael C. Brower

Masters Business Admin

Medical Specialties

David M. Clapper

Director/Board Member

Packaged Software

Brian E. Chee

Corporate Officer/Principal

Medical Specialties

David Renzi

Director/Board Member

Hospital/Nursing Management

Brian E. Chee

Corporate Officer/Principal

Regional Banks

David M. Clapper

Director/Board Member

Specialty Stores

Michael C. Brower

Director of Finance/CFO

San Diego Sport Innovators

Michael C. Brower

Director/Board Member

Medical Specialties

David M. Clapper

Director/Board Member

Critikon, Inc.

David M. Clapper

Director/Board Member

Corinth Medical, Inc.

David M. Clapper

Director/Board Member

Kelley School of Business College/University

David Renzi

Undergraduate Degree

Pharmaceuticals: Major

Brian E. Chee

Director/Board Member

Financial Conglomerates

Brian E. Chee

Director/Board Member

Internet Software/Services

Brian E. Chee

Director/Board Member

KALVISTA PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Renzi

Chief Executive Officer

Packaged Software

Brian E. Chee

Director/Board Member

Medical Specialties

David Renzi

Director/Board Member

Investment Managers

Brian E. Chee

Director/Board Member

Hospital/Nursing Management

Brian E. Chee

Chairman

Investment Managers

Brian E. Chee

Director/Board Member

Financial Conglomerates

David M. Clapper

President

Apparel/Footwear

Michael C. Brower

Director of Finance/CFO

Novacept, Inc.

David M. Clapper

David Renzi

Chief Executive Officer

Corporate Officer/Principal

Household/Personal Care

Michael C. Brower

Founder

Odyssey Golf

Michael C. Brower

Director of Finance/CFO

Statistik

International

Vereinigte Staaten 48
Vereinigtes Königreich 3
Schweiz 2

Sektoral

Health Technology 21
Finance 9
Technology Services 5
Consumer Services 5
Consumer Durables 3

Operativ

Director/Board Member 141
Corporate Officer/Principal 41
Independent Dir/Board Member 26
President 25
Chief Executive Officer 19
  1. Börse
  2. Insiders
  3. Pamela Misajon
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT